Who is sponsoring NCT03311633?

NCT03311633 is sponsored by Carlos A Acosta-Olivo.

What drugs are being tested in NCT03311633?

Interventions in NCT03311633: Percutaneous pinning time.

What condition does NCT03311633 study?

NCT03311633 studies Radius Fracture Distal.

Is NCT03311633 still recruiting?

NCT03311633 is currently completed. Last updated 8 May 2024.

Last reviewed 2024-05-08 · How we verify

NCT03311633

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Complications in Distal Radius Fracture

Completed NA Last updated 8 May 2024

What this trial tests

NA trial testing Percutaneous pinning time in Radius Fracture Distal in 60 participants. Completed in 23 April 2024.

Timeline

29 September 2017

Primary endpoint
20 April 2024

23 April 2024

Quick facts

Lead sponsor	Carlos A Acosta-Olivo
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	29 September 2017
Primary completion	20 April 2024
Estimated completion	23 April 2024
Sites	2 locations across Mexico

Drugs / interventions tested

Percutaneous pinning time

Conditions studied

Radius Fracture Distal — all drugs for Radius Fracture Distal →

Sponsor

Carlos A Acosta-Olivo — full company profile →

Who can join

Adults 18 to 90, any sex, with Radius Fracture Distal. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

BACKGROUND. Distal radius fractures (FRD) are up to 17% of all diagnosed fractures and are the most commonly treated fractures in adult orthopedic patients. The management could be either conservative or surgical, depending on AO bone fracture classification. The principles of good treatment involves an anatomical reduction with a proper immobilization that keep the reduction. OBJECTIVE. Determine if percutaneous pinning for six weeks versus three has major complications in distal radius fractures.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Percutaneous pinning for treating distal radial fractures in adults.
Karantana A, Handoll HH, Sabouni A. · · 2020 · cited 16× · PMID 32032439 · DOI 10.1002/14651858.cd006080.pub3

Verify or expand the search:

Other Carlos A Acosta-Olivo trials

Trials by the same sponsor.

NCT04187014 — Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03311633 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carlos A Acosta-Olivo
Last refreshed: 8 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03311633.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing